• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

mBio . Host cell state: an overlooked factor impacting the production of influenza A deletion-containing viral genomes and non-infectious particles

tetano

Editor, Senior Moderator
mBio


. 2025 Sep 29:e0199125.
doi: 10.1128/mbio.01991-25. Online ahead of print. Host cell state: an overlooked factor impacting the production of influenza A deletion-containing viral genomes and non-infectious particles

Ilechukwu Agu[SUP] 1 [/SUP], Samuel L Díaz-Muñoz[SUP] 1 2 [/SUP]



Affiliations
Free article Abstract

Influenza A virus remains a global public health threat, prompting the need for novel, broad-spectrum therapeutics. Deletion-containing viral genomes (DelVGs) produced during influenza replication have shown broad-spectrum therapeutic potential via defective interference, where DelVG accumulation depletes the relative abundance of standard viral genomes, diminishing the viral yield needed to sustain pathogenesis. Decades of research have focused on the viral factors affecting the production and maintenance of DelVGs in influenza infections. Surprisingly, the study of host factors that affect the emergence of DelVGs has been neglected. Uncovering host factors that affect DelVG production could help predict infection outcomes based on host state; facilitate the manipulation of host metabolism to increase DelVG production, potentially leading to milder clinical outcomes; and enhance biomanufacturing. The therapeutic potential of increasing in situ production of DelVGs is evident, but barriers to progress have persisted for decades, such as a lack of tailored methodologies to reliably quantify defective interference and early research findings that dismissed host cell involvement in the production of DelVGs and the defective interfering particles that carry them. Thus, the molecular mechanism of de novo DelVG production remains unknown in spite of evidence implicating host involvement. This review summarizes (i) newly discovered associations between host cell state and influenza DelVGs, (ii) the extensive host-virus metabolic signaling crosstalk that refocused the host as a potential contributor to DelVG/non-infectious particle production, and (iii) the methodological innovations that facilitated these recent discoveries. We conclude by providing an outlook on new avenues in DelVG basic and applied research.

Keywords: AKT signaling; PI3K; flu; insulin; non-standard viral genomes; sociovirology; virus-virus interactions.

 
Back
Top Bottom